JBIO
Jade Biosciences
JBIO
JBIO
49 hedge funds and large institutions have $396M invested in Jade Biosciences in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 25 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less ownership
Funds ownership: →
17% less capital invested
Capital invested by funds: $475M → $396M (-$79.9M)
72% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 25
Holders
49
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$6.87M | |
| 2 | +$1.95M | |
| 3 | +$662K | |
| 4 |
PL
Parkwood LLC
Cleveland,
Ohio
|
+$507K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$382K |
Top Sellers
| 1 | -$7.28M | |
| 2 | -$1.56M | |
| 3 | -$1.32M | |
| 4 |
BlackRock
New York
|
-$650K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$589K |